Eventually, beta cell exhaustion progresses beyond the point of compensation
These individuals are more likely to benefit from weight loss and reduced insulin doses
Nature 546 , 259264 (2017)
The attendees debated where all these new treatments might fit in, especially with Eli Lilly currently dominating the market for shots and impressing attendees with data from its experimental triple-acting drug retatrutide that produced the most weight loss seen yet
According to clinical trials, its use can provide significant advantages to people suffering from obesity or excess weight, particularly anyone who might not have had success with other therapies
Semaglutide-Specific Risks While Semaglutide is generally well-tolerated, it can cause nausea, vomiting, and digestive issues, especially when first starting